Simultaneous bilateral stereotactic body radiation therapy of two inoperable centrally located pulmonary lesions in a patient with metastatic mesenchymal chondrosarcoma

Claudia Andrä , Chukwuka Eze , Ute Ganswindt , Falk Roeder , Claus Belka , Helmut Ostermann , Farkhad Manapov
{"title":"Simultaneous bilateral stereotactic body radiation therapy of two inoperable centrally located pulmonary lesions in a patient with metastatic mesenchymal chondrosarcoma","authors":"Claudia Andrä ,&nbsp;Chukwuka Eze ,&nbsp;Ute Ganswindt ,&nbsp;Falk Roeder ,&nbsp;Claus Belka ,&nbsp;Helmut Ostermann ,&nbsp;Farkhad Manapov","doi":"10.1016/j.ctrc.2016.02.004","DOIUrl":null,"url":null,"abstract":"<div><p>The treatment recommendations for patients with inoperable residual intrapulmonary metastases from mesenchymal chondrosarcoma after completion of chemotherapy are sometimes controversial. We describe a case of simultaneous bilateral stereotactic body radiation therapy (SBRT) of two relatively large inoperable central pulmonary lesions in a patient with metastatic mesenchymal chondrosarcoma. The primary tumor was treated with complete surgery alone. Pulmonary failure with multiple lesions developed 5 years later. After systemic treatment with eight cycles of doxorubicin/ifosfamide, two relatively large bilateral centrally located metastases (4.7 and 2.1<!--> <!-->cm) remained that were deemed inoperable. The metastases were treated by simultaneous bilateral SBRT. Because of the size and localization of the residual lesions, ablative SBRT protocols seemed unfavorable in respect to awaiting excessive pulmonary toxicity. We therefore used an individualized moderate dose prescription concept. Nevertheless SBRT resulted in excellent long-term outcome without any relevant toxicity.</p></div>","PeriodicalId":90461,"journal":{"name":"Cancer treatment communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ctrc.2016.02.004","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213089616300044","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

The treatment recommendations for patients with inoperable residual intrapulmonary metastases from mesenchymal chondrosarcoma after completion of chemotherapy are sometimes controversial. We describe a case of simultaneous bilateral stereotactic body radiation therapy (SBRT) of two relatively large inoperable central pulmonary lesions in a patient with metastatic mesenchymal chondrosarcoma. The primary tumor was treated with complete surgery alone. Pulmonary failure with multiple lesions developed 5 years later. After systemic treatment with eight cycles of doxorubicin/ifosfamide, two relatively large bilateral centrally located metastases (4.7 and 2.1 cm) remained that were deemed inoperable. The metastases were treated by simultaneous bilateral SBRT. Because of the size and localization of the residual lesions, ablative SBRT protocols seemed unfavorable in respect to awaiting excessive pulmonary toxicity. We therefore used an individualized moderate dose prescription concept. Nevertheless SBRT resulted in excellent long-term outcome without any relevant toxicity.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
同时双侧立体定向放射治疗转移性间充质软骨肉瘤患者两个不能手术的中央位置肺病变
化疗结束后不能手术的间充质软骨肉瘤残余肺内转移患者的治疗建议有时存在争议。我们描述了一例同时双侧立体定向放射治疗(SBRT)的两个相对较大的不能手术的中央肺病变的转移性间充质软骨肉瘤患者。原发肿瘤只用完全手术治疗。5年后出现肺衰竭伴多发病变。在用8个周期的阿霉素/异环磷酰胺进行全身治疗后,仍有两个相对较大的双侧中心转移灶(4.7和2.1 cm)被认为无法手术。转移灶同时行双侧SBRT治疗。由于残余病变的大小和定位,对于等待过度的肺毒性,消融SBRT方案似乎是不利的。因此,我们采用了个体化的中等剂量处方概念。然而,SBRT的长期疗效很好,没有任何相关的毒性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Oral chemotherapy in advanced breast cancer: expert perspectives on its role in clinical practice Activity of trastuzumab-emtansine (TDM1) in HER2-positive breast cancer brain metastases: A case series Pigmentation of the tongue with lapatinib treatment in a patient with advanced breast cancer: A case report Assessment of chemotherapy strategy using bevacizumab for non-squamous non-small cell lung cancer in a real-world setting: A multi-institutional observational study Multiple nodular lung metastases with no obvious primary showing low positive 18-fluoro deoxyglucose (FDG) uptake on positron emission tomography (PET) scan: A unique case of metastatic ameloblastoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1